Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

References

Page 1

	Year	Citations
Categorical Data Analysis Using the SAS System Technometrics EngineeringSymbolic Data AnalysisRegression AnalysisIntroduction Chapter 2Logistic Analysis	1996	1.9K
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis John J. Bissler, Francis X. McCormack, Lisa R. Young, New England Journal of Medicine	2008	1.3K
Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs Sandra L. Dabora, Sergiusz Jóźwiak, David Neal Franz, The American Journal of Human Genetics Mutational AnalysisMendelian DisorderGenetic DisorderGeneticsGenetic Epidemiology	2001	991
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis Darcy A. Krueger, Marguerite M. Caré, Katherine Holland, New England Journal of Medicine	2010	990
Categorical Data Analysis Using The SAS1 System Technometrics Data RepresentationSas1 SystemEngineeringData ScienceData Mining	2001	651
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex David Neal Franz, Jennifer Leonard, Cynthia Tudor, Annals of Neurology	2006	613
Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex Őzgür Sancak, Mark Nellist, Miriam Goedbloed, European Journal of Human Genetics Tuberous Sclerosis ComplexMolecular Diagnostic TechniquesDiagnostic Dna TechniquesGenetic DisorderMedicine	2005	481
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Madeleine Duvic, Ángel G. Martín, Y. Kim, PubMed	2001	437
Subependymal giant cell tumors in tuberous sclerosis complex Suzanne Goh, William E. Butler, Elizabeth A. Thiele Neurology	2004	261
Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial Peter Heald, Marilyn A. Mehlmauer, Ann Martin, Journal of the American Academy of Dermatology Lymphoid NeoplasiaTopical Bexarotene TherapyMedicineTopical DrugDermatology	2003	159

Page 1